These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells. Ali TZ, Epstein JI. Am J Surg Pathol; 2008 Dec; 32(12):1890-5. PubMed ID: 18813120 [Abstract] [Full Text] [Related]
6. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma. Boran C, Kandirali E, Yilmaz F, Serin E, Akyol M. Urol Oncol; 2011 Dec; 29(6):614-23. PubMed ID: 20189848 [Abstract] [Full Text] [Related]
7. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Epstein JI, Egevad L, Humphrey PA, Montironi R, Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122 [Abstract] [Full Text] [Related]
9. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM. Cancer Res; 2002 Apr 15; 62(8):2220-6. PubMed ID: 11956072 [Abstract] [Full Text] [Related]
10. The value of triple antibody (34βE12 + p63 + AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins. Daoud NA, Li G, Evans AJ, van der Kwast TH. J Clin Pathol; 2012 May 15; 65(5):437-40. PubMed ID: 22294716 [Abstract] [Full Text] [Related]
14. Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study. Ng VW, Koh M, Tan SY, Tan PH. Am J Clin Pathol; 2007 Feb 15; 127(2):248-53. PubMed ID: 17210521 [Abstract] [Full Text] [Related]
16. Is atypical adenomatous hyperplasia of the prostate a precursor lesion? Zhang C, Montironi R, MacLennan GT, Lopez-Beltran A, Li Y, Tan PH, Wang M, Zhang S, Iczkowski KA, Cheng L. Prostate; 2011 Dec 15; 71(16):1746-51. PubMed ID: 21480308 [Abstract] [Full Text] [Related]
17. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues. Hameed O, Sublett J, Humphrey PA. Am J Surg Pathol; 2005 May 15; 29(5):579-87. PubMed ID: 15832080 [Abstract] [Full Text] [Related]
18. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Weinstein MH, Signoretti S, Loda M. Mod Pathol; 2002 Dec 15; 15(12):1302-8. PubMed ID: 12481011 [Abstract] [Full Text] [Related]
19. [Detection of P504S (alpha-methylacyl-CoA racemase) in prostatic adenocarcinomas]. Xiao Y, Chen J, Luo YF, Cao JL, Ling Q, Jin F. Zhonghua Yi Xue Za Zhi; 2004 Aug 17; 84(16):1362-6. PubMed ID: 15387946 [Abstract] [Full Text] [Related]
20. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases. Zhao J, Epstein JI. Am J Surg Pathol; 2009 Apr 17; 33(4):583-90. PubMed ID: 19033862 [Abstract] [Full Text] [Related] Page: [Next] [New Search]